Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment
暂无分享,去创建一个
Wanlin Zhu | Simone Reppermund | Henry Brodaty | Wei Wen | Perminder S Sachdev | Kristan Kang | P. Sachdev | J. Trollor | N. Kochan | S. Reppermund | H. Brodaty | W. Wen | M. Slavin | Wanlin Zhu | K. Mather | J. Crawford | K. Kang | Haobo Zhang | Karen A Mather | Nicole A Kochan | Julian N Trollor | John D Crawford | Melissa J Slavin | Haobo Zhang
[1] Xin Yu,et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. , 2003, The American journal of psychiatry.
[2] E. Perry. The cholinergic system in old age and Alzheimer's disease. , 1980, Age and ageing.
[3] C. Bottino,et al. Volumetric MRI Measurements Can Differentiate Alzheimer's Disease, Mild Cognitive Impairment, and Normal Aging , 2002, International Psychogeriatrics.
[4] Oscar L. Lopez,et al. Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease , 2008, Alzheimer's & Dementia.
[5] Katrin Amunts,et al. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain , 2008, NeuroImage.
[6] Henry Brodaty,et al. Effect of different impairment criteria on prevalence of “objective” mild cognitive impairment in a community sample. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[7] H. Hanyu,et al. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. , 2002, AJNR. American journal of neuroradiology.
[8] D. A. Kenny,et al. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.
[9] D. Price,et al. Topography of the Magnocellular Basal Forebrain System in Human Brain , 1984, Journal of neuropathology and experimental neurology.
[10] C. Jack,et al. Mild cognitive impairment: ten years later. , 2009, Archives of neurology.
[11] Sterling C. Johnson,et al. Magnetic Resonance Imaging Characterization of Brain Structure and Function in Mild Cognitive Impairment: A Review , 2008, Journal of the American Geriatrics Society.
[12] Kiralee M. Hayashi,et al. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. , 2006, Archives of neurology.
[13] L. Wilkinson,et al. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system , 1994, Neuroscience.
[14] F. Schmitt,et al. Brain structural alterations before mild cognitive impairment , 2007, Neurology.
[15] John Ashburner,et al. A fast diffeomorphic image registration algorithm , 2007, NeuroImage.
[16] P. Sachdev,et al. The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70–90 years , 2010, International Psychogeriatrics.
[17] Jennifer L. Whitwell,et al. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. , 2008, Archives of neurology.
[18] J. Pantel,et al. Mild Cognitive Impairment in the Elderly is Associated with Volume Loss of the Cholinergic Basal Forebrain Region , 2010, Biological Psychiatry.
[19] H. Soininen,et al. Apolipoprotein E ε4 Allele Is Associated with Increased Atrophy in Progressive Mild Cognitive Impairment: A Voxel-Based Morphometric Study , 2008, Neurodegenerative Diseases.
[20] Hiroaki Kazui,et al. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? , 2005, The American journal of psychiatry.
[21] H. Soininen,et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD , 2004, Neurobiology of Aging.
[22] R. Nicoll,et al. Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells. , 1983, Science.
[23] H. Kraemer,et al. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.
[24] J. Brewer,et al. High-throughput, Fully Automated Volumetry for Prediction of MMSE and CDR Decline in Mild Cognitive Impairment , 2009, Alzheimer disease and associated disorders.
[25] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[26] C. Jack,et al. Patterns of atrophy differ among specific subtypes of mild cognitive impairment. , 2007, Archives of neurology.
[27] K. Amunts,et al. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. , 2010, Cerebral cortex.
[28] Anders M. Dale,et al. Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.
[29] S. Resnick,et al. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI , 2009, Neurology.
[30] H. Möller,et al. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. , 2005, Brain : a journal of neurology.
[31] Peter Stoeter,et al. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment , 2005, NeuroImage.
[32] R. O’Brien,et al. A Caution Regarding Rules of Thumb for Variance Inflation Factors , 2007 .
[33] C. Davies,et al. Cholinergic modulation of hippocampal cells and circuits , 2005, The Journal of physiology.
[34] H C Charles,et al. Impact of APOE in mild cognitive impairment , 2004, Neurology.
[35] J. Berger-Sweeney. The effects of neonatal basal forebrain lesions oncognition : towards understanding the developmental roleof the cholinergic basal forebrain , 1998, International Journal of Developmental Neuroscience.
[36] D. Bennett,et al. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[38] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[39] R. Verwer,et al. ApoE ϵ4 Genotype Is Accompanied by Lower Metabolic Activity in Nucleus Basalis of Meynert Neurons in Alzheimer Patients and Controls as Indicated by the Size of the Golgi Apparatus , 2004, Journal of neuropathology and experimental neurology.
[40] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[41] C. Geula,et al. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase , 1988, The Journal of comparative neurology.